MTCO3P11

Across TCGA pan-cancer cohorts, MTCO3P11 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MTCO3P11 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MTCO3P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTCO3P11 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

DLBC, THYM, and KIRC are the cancer types where MTCO3P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Median	All	0.278	0.767	.003	62	view →
THYM	DFS	Tertile	All	0.687	0.941	<.001	54	view →
KIRC	OS	Median	All	0.526	0.698	.001	49	view →
HNSC	DFS	Median	All	0.782	0.666	.004	28	view →
OV	DFS	Tertile	IV	0.267	0.545	.013	24	view →
LUSC	OS	Tertile	III,IV	0.373	0.888	.002	24	view →
SKCM	OS	Median	All	0.837	0.749	.002	23	view →
KIRP	DFS	Median	All	0.960	0.623	.011	16	view →
ESCA	DFS	Median	All	0.487	0.918	.009	15	view →
THCA	DFS	Tertile	IV	0.447	0.895	.003	15	view →
MESO	DFS	Median	III,IV	0.291	0.429	.020	13	view →
PAAD	OS	Median	All	0.442	0.673	.002	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MTCO3P11–DLBC (DFS)

Open the DLBC breakdown →